146 related articles for article (PubMed ID: 15605361)
1. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
Canevari Rde A; Pontes A; Rogatto SR
Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
[TBL] [Abstract][Full Text] [Related]
2. Allelotype of uterine leiomyomas.
Mao X; Barfoot R; Hamoudi RA; Easton DF; Flanagan AM; Stratton MR
Cancer Genet Cytogenet; 1999 Oct; 114(2):89-95. PubMed ID: 10549262
[TBL] [Abstract][Full Text] [Related]
3. Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis.
Canevari RA; Pontes A; Rosa FE; Rainho CA; Rogatto SR
Am J Obstet Gynecol; 2005 Oct; 193(4):1395-403. PubMed ID: 16202732
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
Quade BJ; Pinto AP; Howard DR; Peters WA; Crum CP
Am J Pathol; 1999 Mar; 154(3):945-50. PubMed ID: 10079273
[TBL] [Abstract][Full Text] [Related]
5. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
[TBL] [Abstract][Full Text] [Related]
6. [The loss of heterozygosity and microsatellite instability analysis in differential diagnostics of leiomyosarcoma and proliferative leiomyoma of the uterus].
Shikeeva AA; Kekeeva TV; Zavalishina LÉ; Andreeva IuIu; Frank GA
Arkh Patol; 2011; 73(4):47-50. PubMed ID: 22164433
[TBL] [Abstract][Full Text] [Related]
7. Association of the shrinkage of uterine leiomyoma treated with GnRH agonist and deletion of long arm of chromosome 7.
Takahashi K; Kawamura N; Tsujimura A; Ichimura T; Ito F; Ishiko O; Ogita S
Int J Oncol; 2001 Jun; 18(6):1259-63. PubMed ID: 11351260
[TBL] [Abstract][Full Text] [Related]
8. Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.
van der Heijden O; Chiu HC; Park TC; Takahashi H; LiVolsi VA; Risinger JI; Barrett JC; Berchuck A; Evans AC; Behbakht K; Menzin AW; Liu PC; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Mol Carcinog; 1998 Dec; 23(4):243-7. PubMed ID: 9869453
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
[TBL] [Abstract][Full Text] [Related]
10. High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci.
El-Rifai W; Sarlomo-Rikala M; Andersson LC; Miettinen M; Knuutila S
Genes Chromosomes Cancer; 2000 Apr; 27(4):387-91. PubMed ID: 10719369
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
[TBL] [Abstract][Full Text] [Related]
12. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas.
Zeng WR; Scherer SW; Koutsilieris M; Huizenga JJ; Filteau F; Tsui LC; Nepveu A
Oncogene; 1997 May; 14(19):2355-65. PubMed ID: 9178912
[TBL] [Abstract][Full Text] [Related]
14. No microsatellite instability using Bethesda panel and revised markers in uterine leiomyomas.
Hong JM; Lee JH; Gwon GJ; Kim DK
APMIS; 2014 Jan; 122(1):1-4. PubMed ID: 24373030
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
Xia JC; Weng DS; Li JT; Qin HD; Mai SJ; Feng BJ; Fan Q; Feng QS; Huang LX; Yu XJ; Pan ZZ; Li YQ; Wang QJ; Zhan YQ; Chen SP; He J; Huang WL; Wu PH; Zeng YX
Cancer Genet Cytogenet; 2006 Apr; 166(2):166-72. PubMed ID: 16631475
[TBL] [Abstract][Full Text] [Related]
16. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.
Zhai YL; Nikaido T; Orii A; Horiuchi A; Toki T; Fujii S
Gynecol Oncol; 1999 Dec; 75(3):453-9. PubMed ID: 10600306
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. Two discrete regions of deletion at 7q in uterine leiomyomas.
Ishwad CS; Ferrell RE; Hanley K; Davare J; Meloni AM; Sandberg AA; Surti U
Genes Chromosomes Cancer; 1997 Jul; 19(3):156-60. PubMed ID: 9218996
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas.
Patrikis MI; Bryan EJ; Thomas NA; Rice GE; Quinn MA; Baker MS; Campbell IG
Mol Carcinog; 2003 Jun; 37(2):61-4. PubMed ID: 12766905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
